2014, Volume 21, Supplement 1: Rivaroxaban in non-valvular atrial fibrillation: European experience
September 2014 Br J Cardiol 2014;21(suppl 1):S1–S11
Rivaroxaban in non-valvular AF – UK experience in perspective
Diana A Gorog
Insights from the world of cardiology...
September 2014 Br J Cardiol 2014;21(suppl 1):S1–S11
Rivaroxaban in non-valvular AF – French experience in perspective
Laurent Fauchier, Edouard Siméon, Christophe Saint-Etienne
Insights from the world of cardiology...
September 2014 Br J Cardiol 2014;21(suppl 1):S1–S11
The French rivaroxaban experience: what we call progress is the exchange of one nuisance for another*
Thibault Leclerq, Samuel Goussot, Karim Stamboul, Yves Cottin, Luc Lorgis
Insights from the world of cardiology...
September 2014 Br J Cardiol 2014;21(suppl 1):S1–S11
Novel oral anticoagulants in daily clinical practice – German experience with rivaroxaban
Ingo Ahrens, Christoph Bode
Insights from the world of cardiology...
September 2014 Br J Cardiol 2014;21(suppl 1):S1–S11
European experiences reviewed
David Hargroves
Insights from the world of cardiology...
